Image source: Shutterstock

Highlights

  • Chrysos Corporation signs breakthrough contract with US$60B gold miner Newmont.

  • PhotonAssay technology to be deployed in Ghana from 1HFY26.

  • Stock hits $4.93, making C79 the ASX’s top gainer by midday Friday.

Chrysos Corporation Ltd (ASX:C79) rocketed 19.4% higher to $4.93 in early Friday trade, securing its spot as the top-performing ASX stock during the morning session. The rally was sparked by the announcement that Newmont Corporation (ASX:NEM), one of the world's largest gold producers, has agreed to adopt Chrysos’ PhotonAssay technology at one of its projects.

Headquartered in Adelaide, Chrysos is making waves with its patented PhotonAssay solution — a cutting-edge, non-destructive alternative to traditional fire assays. The technology, which uses X-rays instead of heat, enables rapid analysis of gold, silver, and copper ores in as little as two minutes. The company also touts its environmentally friendly footprint by eliminating the need for lead-based processes.

The Newmont deal is being hailed as a major commercial win. While specific financial details of the master services agreement and initial lease contract were not disclosed, Chrysos confirmed the technology will be deployed at a Newmont site in Ghana in the first half of FY26. The arrangement will include a fee-per-sample structure.

Chrysos CEO Dirk Treasure framed the agreement as part of a broader strategy to secure top-tier mining clients:

“We are continuing our strategy of converting the world’s biggest gold miners to PhotonAssay. We are pleased to see top- and mid-tier producers adopting our technology at their projects.”

With a US$60 billion market capitalisation, Newmont’s endorsement is expected to strengthen Chrysos’ credibility and market reach, especially in the gold sector. The latest deal builds on a growing trend of industry adoption.

C79 shares last traded at $4.93.